Alpha Ketoanalogue
| Brand | Aplazar |
| Manufacturer | Fresenius Kabi India Pvt Ltd |
| Form | Tablet |
| Treatment | Chronic Kidney Disease |
| Pack Size | 10*10 Tablet |
| Pack Type | Strip |
| Strength | 200 mg |
| Packaging Size | 10 x 10 tablets |
| Packaging Type | Blister |
| Shelf Life | 36 Months |
| Prescription/Non-Prescription | Prescription |
| Dosage Form | Tablet |
| Storage Temperature | Below 25 degree c |
| Composition | Alpha Ketoanalogue |
| Country of Origin | Made in India |
Features:
- It is part of the conservative treatment of patients with chronic kidney disease.
- It contains amino acids, partly in form of there corresponding-ketoanalogues, essential for patients.
- In combination with a protein-restricted diet, it is an excellent tool to treat chronic kidney disease in the predialysis period.
Benefits:
- Reduction of uraemic symptoms, which are largely due to an accumulation of degradation products of the protein metabolism
- Preservation of the residual renal function and therefore slowing down the rate of progression of the chronic kidney disease and delaying the onset of dialysis
- Preservation of the nutritional status, despite the marked reduction of the daily protein intake
- Improvement of metabolic complications due to renal insufficiency (e.g. proteinuria, disturbances in calcium-phosphate, carbohydrate and lipid metabolism)
Characteristics: One film-coated tablet contains
- Calcium 3-methyl-2-oxovaleric acid (a-ketoanalogue of isoleucine, Ca-salt) 67 mg
- Calcium-methyl-2-oxovaleric acid (a-ketoanalogue of leucine, Ca-salt) 101 mg
- Calcium-2-oxo-3-phenylpropionic acid (a-ketoanalogue of phenylalanine, Ca-salt) 86 mg
- Calcium-3-methyl-2-oxobutyric acid (a-ketoanalogue of valine, Ca-salt) 68 mg
- Calcium-DL-2-hydroxy-4-(methylthio)-butyric acid (a-hydroxyanalogue ofmethionine) 59mg, Ca-salt 105 mg
- L-lysine acetate (= L-lysine 75 mg) 53 mg
- L-threonine 23 mg
- L-tryptophan 38 mg
- L-histidine 30 mg
- L-tyrosine
- Total nitrogen content per tablet: 36 mg
- Calcium content per tablet: 1.25 mmol = 0.05 g
Other Ingredients:
- Corn starch, crospovidone, povidone (K-value 29-32), talc, highly dispersed silicon dioxide, magnesium stearate, macrogol 6000, colouring agents E 104, E 171, alkaline polymethacrylate, glycerol triacetate.
Indications:
- Prevention & therapy of damages due to CKD till GFR is 15 ml/min,i.e.stages II, III & IV of CKD
Dosage:
- Dosage / Administration: For Oral Use.
- If not otherwise prescribed, take 4-8 tablets three times a day during meals. swallow whole. This dosage applies to adults (70kg/BW)
Note:
- Take according to medical prescription
Warning:
- To be sold by retail on prescription of RMP only
Additional Information:
- Item Code: 10009
- Production Capacity: GOOD
- Delivery Time: SAME DAY
- Packaging Details: 10X10 BLISTER
View Complete Details
- Developed and Managed by IndiaMART InterMESH Limited











